Unicycive Therapeutics Inc (UNCY)

08:08 AM

Unicycive Therapeutics Announces the Publication of Oxylanthanum Carbonate Pivotal Trial Data in Clinical Journal of the American Society of Nephrology - The Manila Times

08:08 AM

08:00 AM

Revolutionary Kidney Disease Drug Shows 90% Success Rate with Just 3 Pills Daily, New Study Reveals - Stock Titan

08:00 AM

Jul 23, 2025

Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jul 23, 2025

Jul 23, 2025

Is Unicycive Therapeutics Inc. a good long term investmentFree Market Dynamics Reports - jammulinksnews.com

Jul 23, 2025

Jul 22, 2025

What drives Unicycive Therapeutics Inc. stock priceOver 200% growth - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Unicycive Therapeutics Inc. Stock Analysis and ForecastFree Smart Trading Workshop - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Unicycive Therapeutics, Inc. (UNCY) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Jul 22, 2025

Jul 22, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Unicycive Therapeutics, Inc.UNCY - WV News

Jul 22, 2025

Jul 22, 2025

Is Unicycive Therapeutics (NASDAQ:UNCY) In A Good Position To Invest In Growth? - Yahoo Finance

Jul 22, 2025

Jul 22, 2025

What analysts say about Unicycive Therapeutics Inc. stockExceptional market performance - jammulinksnews.com

Jul 22, 2025

Jul 21, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages Unicycive Therapeutics, Inc. (UNCY) Investors to Inquire about Securities Investigation - ACCESS Newswire

Jul 21, 2025

Jul 20, 2025

Best Stocks for a Post COVID Recovery in India Financial Expert RecommendationsFree Stock Market Trend Analysis - PrintWeekIndia

Jul 20, 2025

Jul 19, 2025

What analysts say about Palladyne AI Corp. stockRapid growth trajectories - jammulinksnews.com

Jul 19, 2025

Jul 19, 2025

EWTX Investors Have Opportunity to Join Edgewise Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - Business Wire

Jul 19, 2025

Jul 19, 2025

ALT Investors Have Opportunity to Join Altimmune, Inc. Fraud Investigation with the Schall Law Firm - Business Wire

Jul 19, 2025

Jul 19, 2025

UNCY Investors Have Opportunity to Join Unicycive Therapeutics, Inc. Fraud Investigation With the Schall Law Firm - Business Wire

Jul 19, 2025

Jul 18, 2025

Published on: 2025-07-18 04:29:16 - Newser

Jul 18, 2025

Jul 17, 2025

Why Unicycive Therapeutics Inc. stock is on top investor watchlistsDaily Top Gainers - Newser

Jul 17, 2025

Jul 15, 2025

Why Unicycive Therapeutics Inc. stock attracts strong analyst attentionFast Moving Stock Alerts - Newser

Jul 15, 2025

Jul 15, 2025

How Unicycive Therapeutics Inc. stock performs during market volatilityReal Chart Play - Newser

Jul 15, 2025

Jul 15, 2025

What makes Unicycive Therapeutics Inc. stock price move sharplyFree Trading Strategy Suggestions - Newser

Jul 15, 2025

Jul 14, 2025

Transcript : Unicycive Therapeutics, Inc. Presents at H.C. Wainwright 4th Annual Kidney Virtual Conference, Jul-14-2025 11 - MarketScreener

Jul 14, 2025

Jul 13, 2025

Unicycive Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference - 富途牛牛

Jul 13, 2025

Jul 12, 2025

Pomerantz LLP Investigates Unicycive Therapeutics Securities Fraud Claims. - AInvest

Jul 12, 2025

Jul 09, 2025

Unicycive Regains Nasdaq Compliance After Stock Split - The Globe and Mail

Jul 09, 2025

Jul 09, 2025

Unicycive regains Nasdaq compliance after reverse stock split By Investing.com - Investing.com South Africa

Jul 09, 2025

Jul 08, 2025

Unicycive regains Nasdaq compliance after reverse stock split - Investing.com

Jul 08, 2025

Jul 08, 2025

Unicycive Therapeutics Regains Compliance with Nasdaq Listing Standards Following Share Price Recovery - Quiver Quantitative

Jul 08, 2025

Jul 08, 2025

Unicycive Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewswire

Jul 08, 2025

Jul 08, 2025

Unicycive Successfully Maintains Nasdaq Listing Following 1:10 Reverse Stock Split - Stock Titan

Jul 08, 2025

Jul 08, 2025

Unicycive Therapeutics (NASDAQ:UNCY) Trading 2% Higher – Time to Buy? - Defense World

Jul 08, 2025

Jul 07, 2025

Unicycive Therapeutics to Participate in H.C. Wainwright 4th Annual Kidney Virtual Conference - Nasdaq

Jul 07, 2025

Jul 07, 2025

Clinical-Stage Kidney Disease Biotech Unicycive Reveals Latest Therapeutic Progress at Major Healthcare Conference - Stock Titan

Jul 07, 2025

Jul 03, 2025

Lost Money on Unicycive Therapeutics, Inc. (UNCY)? Possible FraudContact Levi & Korsinsky Today - ACCESS Newswire

Jul 03, 2025

Jul 02, 2025

Unicycive Therapeutics - The Pharma Letter

Jul 02, 2025

Jul 02, 2025

Unicycive Shares Sink After FDA Issues Response Letter on Kidney Drug Filing - MSN

Jul 02, 2025

Jul 02, 2025

Ongoing Unicycive Therapeutics, Inc. (UNCY) Investigation: Protect Your RightsContact Levi & Korsinsky - ACCESS Newswire

Jul 02, 2025

Jul 02, 2025

Ongoing Securities Investigation Into Unicycive Therapeutics, Inc. (UNCY)Contact Levi & Korsinsky - ACCESS Newswire

Jul 02, 2025

Jul 01, 2025

Unicycive stock falls as FDA plans complete response letter for OLC - Investing.com India

Jul 01, 2025